Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1993
11/11/1993WO1993021895A1 Scalp care product composition
11/11/1993DE4214953A1 Arzneimittel zur Erhöhung des Testosteronspiegels Medicines to increase testosterone levels
11/11/1993CA2134675A1 Development of a vector to target gene expression to the epidermis of transcenic animals
11/11/1993CA2134670A1 Constitutive and inducible epidermal vector systems
11/11/1993CA2134564A1 Recombinant stimulating factor of the neu receptor
11/11/1993CA2133985A1 Pharmaceutical compositions for inhibiting bone loss containing 3 and 4-substituted 2(5h)-furanones
11/11/1993CA2133984A1 N-aryloxy(thio)alkyl-azacycloalkanes useful as calcium channel antagonists
11/10/1993EP0569337A1 Heteroatoms-containing tricyclic compounds
11/10/1993EP0569276A1 Novel use of enantiomers derived from (S)-2-amino-3-(3,4-dichlorobenzyl)-1-propanol
11/10/1993EP0569122A1 Pyrrole propionic acid amide, its production and use as calpain inhibitor
11/10/1993EP0569113A1 Liposome compositions of porphyrin photosensitizers
11/10/1993EP0569042A1 Medical uses of IL-1 beta
11/10/1993EP0568622A1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp)
11/10/1993EP0552302A4 Method of inhibiting transcription utilizing nuclear receptors
11/09/1993US5260479 Inhibitors of farnesyl protein transferase
11/09/1993US5260465 Inhibitors of farnesyl protein transferase
11/09/1993US5260440 Pyrimidine derivatives
11/09/1993US5260421 Site-directed mutagenesis modified glycoprotein hormones
11/09/1993US5260329 Angiogenesis inhibitors
11/09/1993US5260322 Angiotension II antagonists in the treatment of hyperuricemia
11/09/1993US5260314 Certain 3-(1,2,5-oxa- or thiadiazol-4-yl)-1-azabicyclo [2.2.2]octanes having pharmaceutical properties
11/09/1993US5260303 Imidazopyridines as serotonergic 5-HT3 antagonists
11/09/1993US5260282 Saliva substitute
11/09/1993US5260224 Tissue injury prevention
11/09/1993CA1324155C Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/09/1993CA1324143C Quinoline dioic acids and amides
11/09/1993CA1324139C 2-phenyl-3-acylaminomethyl-imidazo[1,2-a]pyridine derivatives
11/09/1993CA1324133C N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
11/09/1993CA1324098C Serum-free medium for the proliferation of lymphokine-activated killer cells
11/09/1993CA1324095C Recombinant ricin toxin
11/06/1993CA2095509A1 Enantiomeres derives du (s)-amino-2-dichloro-3,4-benzyl) -2-propanol-1
11/03/1993EP0568289A2 Benzothiophenes and thienothiophenes and related compounds useful, for example, as urokinase inhibitors
11/03/1993EP0568200A2 Pharmaceutical and foodstuff compositions containing transferrius and antibacteral agents for potentiating host defense activity and the treatment of infections
11/03/1993EP0568136A1 Indole-2-carboxylic acid derivatives
11/03/1993EP0567966A1 Cyclic imino derivatives, medicaments containing these compounds and processes for the production thereof
11/03/1993EP0567626A1 Amylin agonist peptides and uses therefor
11/03/1993EP0567578A1 Laminin a chain domain vi polypeptides
11/03/1993EP0567566A1 Methods for treating tumor necrosis factor mediated diseases
11/03/1993EP0567528A1 Depot formulations
11/03/1993EP0450041B1 Orally administered porphyrins to control intestinal iron absorption
11/03/1993EP0374188B1 Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/03/1993EP0357788B1 Pyridazinone derivatives
11/03/1993CN1077955A Heterocyclic derivatives
11/03/1993CN1077954A 新的苯并吡喃衍生物 New benzopyran derivatives
11/03/1993CN1077953A 乙酸衍生物 Acetic acid derivatives
11/02/1993US5258402 Imidate derivatives of sulfamates
11/02/1993US5258371 Method to reduce connective tissue destruction
11/02/1993US5258287 DNA sequences and hybrids
11/02/1993CA2094332A1 Urokinase inhibitors
10/1993
10/29/1993CA2095009A1 Cyclic imino derivatives
10/28/1993WO1993021328A1 Polypeptides having kinase activity, their preparation and use
10/28/1993WO1993021318A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
10/28/1993WO1993021302A1 Cadherin materials and methods
10/28/1993WO1993021227A1 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
10/28/1993WO1993021226A1 Cartilage matrix protein and methods for use
10/28/1993WO1993021215A1 Peptides having tachykinin antagonist activity
10/28/1993WO1993021187A1 7-DISUBSTITUTED-METHYL-4-OXO-3H^_,5H^_-PYRROLO[3,2-d^_]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME
10/28/1993WO1993021182A1 Heteroaromatic 5-hydroxytryptamine receptor agonists
10/28/1993WO1993021177A1 Indole derivatives as 5-ht1-like agonists
10/28/1993WO1993021172A1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
10/28/1993WO1993021170A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same
10/28/1993WO1993021159A1 Quinoline derivatives as leukotriene antagonists
10/28/1993WO1993021158A1 Pyridine-substituted benzyl alcohols as leukotriene antagonists
10/28/1993WO1993021155A1 Perhydroisoindole derivatives as p substance antagonists
10/28/1993WO1993021153A1 Indole-2-carboxylic acid derivatives
10/28/1993WO1993021149A1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase
10/28/1993WO1993021146A1 Compounds having selectivity for retinoid x receptors
10/28/1993WO1993020839A2 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality
10/28/1993WO1993020827A1 Preparations of low molecular weight hyaluronic acid for stimulating bone formation
10/28/1993WO1993020826A1 Pharmaceutical composition
10/28/1993WO1993020821A1 Agents for treating substance abuse disorders
10/28/1993WO1993020816A1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
10/28/1993WO1993020807A1 Amines as inhibitors of squalene synthase
10/28/1993WO1993020696A1 Regulation of the immune system
10/28/1993WO1993018762A3 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists
10/28/1993WO1993016719A3 Use of platelet derived growth factor in ophthalmic wound healing
10/28/1993WO1993009222A3 Transfection of vertebrate cells e.g. by homologous recombination
10/28/1993CA2133840A1 Perhydroisoindole derivatives used as p substance antagonists
10/28/1993CA2133346A1 7-disubstituted-methyl-4-oxo-3h,5h-pyrrolo¬3,2-d|pyrimidine and pharmaceutical uses and compositions containing the same
10/28/1993CA2133078A1 Heteroaromatic 5-hydroxytryptamine receptor agonists
10/28/1993CA2132723A1 Pyridine-substituted benzyl alcohols as leukotriene antagonists
10/28/1993CA2130096A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives; process for preparing the same and therapeutic agents containing them
10/28/1993CA2118503A1 Peptides having tachykinin antagonist activity
10/28/1993CA2118253A1 Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
10/28/1993CA2117780A1 Cartillage matrix protein and methods for use
10/27/1993EP0567353A1 Use of 1-alpha,25-dihydroxy-22(E)-dehydro-vitamin D3 for the manufacture of a medicament for the treatment of osteoporosis
10/27/1993EP0567352A1 Use of 1-alpha,24(R)-dihydroxy-22(E)-dehydro-vitamin D3 for the manufacture of a medicament for the treatment of osteoporosis
10/27/1993EP0567251A1 Treatment of neurodegenerative diseases
10/27/1993EP0567250A1 Treatment of neurodegenerative diseases
10/27/1993EP0567094A2 Hydrazoadenosines
10/27/1993EP0566919A1 2,4-dioxoimidazoline derivatives
10/27/1993EP0566593A1 N-hydroxyurea derivatives as antiallergy and antiinflammatory agents
10/27/1993EP0566589A1 N-alkyl quinuclidinium salts as substance p antagonists
10/27/1993EP0394349B1 Wound healing
10/27/1993CN1077711A Cycloalkyl-and heterocyclyl-substituted imidazolylpropenoic acid derivatives
10/27/1993CN1077710A Sulphonylbenzyl-substituted imidazoles
10/27/1993CN1077597A Instant golden tea and preparing process thereof
10/27/1993CN1022566C Process for preparation of substituted 1-piperidylalkylene-pyridopyrimidone or thiazolpyrimidone
10/26/1993US5256789 Antiinflammatory hydroxamic acids and N-hydroxyureas
10/26/1993US5256671 A prodrug as tachykinin antagonists for treating headaches, pain or inflammation
1 ... 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 ... 1564